Objetivo
Relieving serious health-related suffering for patients in palliative and end-of-life care, be it physical, psychological, social, or spiritual, is a global ethical responsibility. However, the profound psycho-emotional and existential distress entailed by such suffering, despite often being an enormous burden for both patients and their loved ones, remains a field largely overlooked by health care providers and the scientific community. Those people may develop mood or anxiety disorder for which neither non-pharmacological nor pharmacological interventions exist. In this context, we believe it is now time to target these unmet needs in the palliative care population. We want to initiate a paradigm shift at the boundaries between palliative care, psychiatry, psychology, neuroscience, and spiritual care. Our starting point is the preliminary results being reported for administration of psilocybin, the main psychoactive compound of so-called ‘psychedelic mushrooms’, in patients with depression. The objective of our project is thus to examine the clinical effect of a cutting-edge, individualised and patient-centred, open and standardised Psilocybin Therapy, addressing these unmet needs of patients in palliative care. We will show high quality evidence via a multi-centre Randomised Clinical Trial of the value of our therapeutic model in patients (and for the following four conditions: COPD, Atypical Parkinsonian Disorders, ALS, and Multiple Sclerosis), their loved ones and care providers, in a diverse sample of the European population, in addition to better understand the mechanisms of therapeutic change of our model. Finally, our project will establish a sustainable, multi-disciplinary, ecosystem of key European stakeholders jointly contributing to the medical use of psychedelic research and innovation, paving the way towards an ethical and cost-effective deployment of such a new line of care for patients in European palliative care service providers.
Ámbito científico
Palabras clave
Programa(s)
Convocatoria de propuestas
Consulte otros proyectos de esta convocatoriaRégimen de financiación
HORIZON-RIA - HORIZON Research and Innovation ActionsCoordinador
9713 GZ Groningen
Países Bajos
Ver en el mapa
Participantes (18)
75647 Uppsala
Ver en el mapa
Organización definida por ella misma como pequeña y mediana empresa (pyme) en el momento de la firma del acuerdo de subvención.
1165 Kobenhavn
Ver en el mapa
111 37 Stockholm
Ver en el mapa
Organización definida por ella misma como pequeña y mediana empresa (pyme) en el momento de la firma del acuerdo de subvención.
1107TN AMSTERDAM
Ver en el mapa
31080 Pamplona
Ver en el mapa
751 05 Uppsala
Ver en el mapa
1400-038 Lisboa
Ver en el mapa
10691 Stockholm
Ver en el mapa
9712CP Groningen
Ver en el mapa
250 67 Klecany
Ver en el mapa
1800 Vilvoorde
Ver en el mapa
10430 Rosiere Pres Troyes
Ver en el mapa
3400 Hillerod
Ver en el mapa
1000 BRUSSELS
Ver en el mapa
114 32 STOCKHOLM
Ver en el mapa
3818 LE AMERSFOORT
Ver en el mapa
67000 Strasbourg
Ver en el mapa
106 40 STOCKHOLM
Ver en el mapa